C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. (Q38964120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Anna Laura Di Pace

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Giovanni Muto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Michele Signore

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Giuseppe Simone

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Désirée Bonci

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

A Cannistraci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

A Addario

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

L Grassi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

D Collura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

L De Salvo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

S Sentinelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

M Costantini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

S Nanni

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

A Farsetti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

V Coppola

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

R De Maria

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

13 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

3718-3728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28192399%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2016.505

2 April 2020

exact match

0 references

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Abiraterone and increased survival in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Androgen receptor as a target in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Molecular biology of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The dedifferentiation of metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Prostate cancer and the met hepatocyte growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Characterization of the rearranged tpr-met oncogene breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Application of molecular technologies for phosphoproteomic analysis of clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The RUNX genes: gain or loss of function in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Watchful waiting and active surveillance: the current position

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

MET expression during prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.505

Androgen receptor gene expression in human prostate carcinoma cell lines

31 March 2020

1 reference

12 December 2020

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

1 reference

12 December 2020

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

1 reference

12 December 2020

The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

1 reference

12 December 2020

Activation of the met proto-oncogene in a human cell line.

1 reference

12 December 2020

Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma

1 reference

12 December 2020